R. Roberts

发表

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma

L. Rimsza, T. Grogan, T. Miller, 2007, Laboratory Investigation.

Activation of the cellular harvey ras gene in mouse skin tumors initiated with urethane

R. Roberts, A. Cress, G. T. Bowden, 1989, Molecular carcinogenesis.

Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy

R. Roberts, R. Taetle, B. Hedlund, 1996, British journal of haematology.

Gene Expression Differences between Low and High Stage Diffuse Large B Cell Lymphoma (DLBCL).

L. Staudt, A. Rosenwald, W. Chan, 2006 .

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

L. Staudt, A. Rosenwald, W. Chan, 2004, Blood.

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.

Robin A Roberts, Margaret M Briehl, L. Rimsza, 2005, Blood.

Serum erythropoietin levels during infancy: associations with erythropoiesis.

R. Roberts, J. Widness, R. Schmidt, 1996, The Journal of pediatrics.

Plasma Transferrin Receptor Levels and Indices of Erythropoiesis and Iron Status in Healthy Term Infants

R. Roberts, J. Widness, P. Kling, 1998, Journal of pediatric hematology/oncology.

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

L. Staudt, A. Rosenwald, W. Chan, 2005, Blood.

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.

L. Staudt, A. Rosenwald, W. Chan, 2006, Blood.

Human Milk as a Potential Enteral Source of Erythropoietin

R. Roberts, O. Koldovský, A. Philipps, 1998, Pediatric Research.

Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival.

L. Rimsza, T. Grogan, R. Roberts, 2006, Archives of pathology & laboratory medicine.

Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.

D. Alberts, R. Roberts, G. T. Bowden, 1985, Cancer research.

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.

L. Rimsza, T. Grogan, T. Miller, 2005, Blood.